154 related articles for article (PubMed ID: 18270789)
21. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
22. A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
Billio A; Svaldi M; Morello E; Amato B; Coser P
Am J Hematol; 2006 Oct; 81(10):798-9. PubMed ID: 16838326
[No Abstract] [Full Text] [Related]
23. A rapidly growing lymphoma and tumor lysis syndrome in a toddler.
Green HL; Rytting ME; Cox CS
JAAPA; 2010 Aug; 23(8):30, 32-4. PubMed ID: 20821911
[No Abstract] [Full Text] [Related]
24. A rare case of ovarian Burkitt lymphoma associated tumor lysis syndrome.
Cui T; Wang C; He H; Shi G; Hu L
Eur J Gynaecol Oncol; 2010; 31(2):209-10. PubMed ID: 20527243
[TBL] [Abstract][Full Text] [Related]
25. Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line.
Deyab M; Elbanani A; Tabal S; Geriani H; Lamami Y; Bredan A; Abulayha A
Cancer Biother Radiopharm; 2014 Mar; 29(2):87-90. PubMed ID: 24256491
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Barnes JA; Lacasce AS; Feng Y; Toomey CE; Neuberg D; Michaelson JS; Hochberg EP; Abramson JS
Ann Oncol; 2011 Aug; 22(8):1859-64. PubMed ID: 21339382
[TBL] [Abstract][Full Text] [Related]
27. [Burkitt's lymphoma: a model for pediatric oncology].
Philip T; Bergeron C
Arch Pediatr; 2000 Sep; 7(9):924-6. PubMed ID: 11028198
[No Abstract] [Full Text] [Related]
28. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.
Saccente SL; Kohaut EC; Berkow RL
Pediatr Nephrol; 1995 Oct; 9(5):569-73. PubMed ID: 8580012
[TBL] [Abstract][Full Text] [Related]
29. Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation.
Grigg AP; Seymour JF
Leuk Lymphoma; 2002 Apr; 43(4):889-92. PubMed ID: 12153181
[TBL] [Abstract][Full Text] [Related]
30. The infectious consequences of rituximab addition to fludarabine-containing regimens.
Tam CS; Seymour JF
Blood; 2006 Apr; 107(7):3013-4. PubMed ID: 16554491
[No Abstract] [Full Text] [Related]
31. Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
Umeda K; Fujino H; Saida S; Kato I; Hiramatsu H; Yamada T; Hori T; Adachi S; Heike T; Watanabe K
Pediatr Int; 2015 Apr; 57(2):e30-3. PubMed ID: 25868956
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
33. A rare cause of gastric malignancy: Burkitt's lymphoma.
Doycheva I; Tanner S; Zhou D; Samadder NJ
Endoscopy; 2013; 45 Suppl 2 UCTN():E432-3. PubMed ID: 24338176
[No Abstract] [Full Text] [Related]
34. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
[TBL] [Abstract][Full Text] [Related]
35. Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
Seifert G; Reindl T; Lobitz S; Seeger K; Henze G
Haematologica; 2006 Jun; 91(6 Suppl):ECR23. PubMed ID: 16785126
[TBL] [Abstract][Full Text] [Related]
36. Acute tumor lysis syndrome in acute lymphoblastic leukemia and Burkitt's lymphoma: experience in a single centre in Kuwait.
al-Bahar S; Pandita R; Dhabhar BN; al-Bahar E
Ann Oncol; 1994 Apr; 5(4):379. PubMed ID: 8075042
[No Abstract] [Full Text] [Related]
37. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
38. [Burkitt's lymphoma and tumor lysis syndrome].
Gómez Campderá FJ; López Gómez JM; Delgado J; Ramos M; Morales JL; Lugue A; Gómez Campderá J
Rev Clin Esp; 1985 Mar; 176(4):210-1. PubMed ID: 4001471
[No Abstract] [Full Text] [Related]
39. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
Cohen Y; Amir G; Rachmilewitz EA; Polliack A
Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488
[No Abstract] [Full Text] [Related]
40. Burkitt's lymphoma.
Molyneux EM; Rochford R; Griffin B; Newton R; Jackson G; Menon G; Harrison CJ; Israels T; Bailey S
Lancet; 2012 Mar; 379(9822):1234-44. PubMed ID: 22333947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
